Nonetheless, we were able to assess that TM supplementation resulted in modulation of ERK1/2 phosphorylation in tumor cells in a xenograft model of BRAFV600E-derived colorectal tumors. This evidence concerns the gene MAPK3 and colorectal neoplasm.